Development of an antibody-targeted drug/miRNA/peptide delivery system for effective prevention of restenosis

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1073591

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The re-blocking of vessels after surgery occurs up to 50% of patients, and none of the preventive approaches are cost-effective and safe enough. This project aims to develop a nano-scaled therapeutics delivering combination therapies to effectively prevent the re-blockage after surgery. If successful, this research will present a whole new range of therapeutic agent that prevents the patient from developing clots after surgery, improving the productivity and health of patients with reduced cost.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Early Career Fellowships

Funding Amount: $319,064.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biomaterials

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

RNA interference | artery wall | biomaterials | biomedical engineering | cardiovascular disease prevention | drug delivery systems | gene delivery | in vitro | in vivo | restenosis

Related Links